Interventional cardiology devices are minimally invasive devices used in the detection and treatment of coronary artery disease. Interventional cardiology involves various non-surgical procedures for treating cardiovascular disease by using drug-eluting stents, bare-metal stents, percutaneous transluminal coronary angioplasty (PTCA) and cutting balloon catheters. Interventional cardiology is a minimally invasive catheter based technology that enables treatment of coronary artery disease (coronary blockages or narrowing of the coronary artery restricting normal blood flow). Rising incidences of coronary artery disease, increasing lifestyle disorders such as obesity and growing disposable income are primarily leading to increase in the number of percutaneous interventions.
The global interventional cardiology devices market report provides market size estimates (Revenue US$ million – 2014 to 2021) for key market segments based on the type of device used (stents – bare metal, bio-absorbable, drug eluting; catheters – angiography, guiding, IVUS, pulmonary arterial catheters; PTCA balloons – normal, drug eluting, cutting, scoring; imaging systems such as FFR, IVUS, OCT; PTCA guidewires, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).
The global interventional cardiology devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global interventional cardiology devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global interventional cardiology devices market and included in this report are Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Medtronic, plc, St. Jude Medical, Inc., Smiths Medical, and Terumo Medical Corporation.